European Biotech Investment: Growth and Evolution

Exploring the surge in biotech investment during the pandemic, the changing landscape of European biotech post-pandemic, and the enthusiasm in the market despite receiving a smaller fraction of investment compared to the US. Highlights include funds raised by firms like Forbian and Biogeneration Ventures, the increasing number of players, and the leadership role of certain organizations in advancing biotech in Europe.